Heidelberg Pharma AG
XETRA:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
Bureau Veritas SA
PAR:BVI
|
FR |
|
C
|
Cadence Design Systems Inc
F:CDS
|
US |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:NBY
|
US |
|
A
|
Amper SA
XMUN:APR
|
ES |
|
Juventus FC SpA
MIL:JUVE
|
IT |
|
Chocoladefabriken Lindt & Spruengli AG
OTC:LDSVF
|
CH |
Shareholder Yield
Current shareholder yield for HPHA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HPHA Price
Heidelberg Pharma AG
| Average Annual Return | -21.22% |
| Standard Deviation of Annual Returns | 14.7% |
| Max Drawdown | -75% |
| Market Capitalization | 132.4m EUR |
| Shares Outstanding | 46 780 000 |
| Percentage of Shares Shorted |
N/A
|
HPHA Return Decomposition
Main factors of price return
Stock Splits
HPHA's latest stock split occurred on Nov 7, 2017
The company executed a 586-for-563 stock split, meaning that for every 563 shares held, investors received 586 new shares.
Before the split, HPHA traded at 2.947 per share. Afterward, the share price was about 2.802.
The adjusted shares began trading on Nov 7, 2017. This was stock split number 9 in HPHA's history, following the previous one in Apr 26, 2017.
